BRD2 and hypogonadotropic hypogonadism: Moreover, FSH treatment has the potential to improve sperm number and motility in patients with hypogonadotropic hypogonadism or normogonadotropic patients with idiopathic impairment of spermatogenesis, highlighting the importance of obtaining a better understanding of FSH signaling in humans [31–34].